Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Orexigen
Orexigen
Analyst: FDA Won't Pull Permit On Orexigen Therapeutics
Yahoo/Benzinga
Sat, 03/7/15 - 11:09 am
FDA
Orexigen
Contrave
Top FDA Official Says Orexigen Study Result 'Unreliable,' 'Misleading'
Forbes
Fri, 03/6/15 - 07:43 am
FDA
Orexigen
Contrave
Takeda Disagrees With Orexigen Over Data Disclosure
Forbes
Thu, 03/5/15 - 05:37 pm
Takeda
Orexigen
Contrave
The FDA Is Forcing Orexigen To Do A Second Safety Study Because Of Contrave Disclosures
Forbes
Wed, 03/4/15 - 08:26 am
FDA
Orexigen
Contrave
Orexigen Soars On Obesity Drug's Surprise Health Boon
Investors.com
Wed, 03/4/15 - 08:14 am
Orexigen
Contrave
Orexigen misses 4Q profit forecasts
Yahoo/AP
Wed, 02/25/15 - 04:52 pm
Orexigen
earnings
Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus
TheStreet.com
Sat, 02/21/15 - 09:44 am
obesity
Orexigen
Arena
Vivus
Belviq
Contrave
Qsymia
Vivus' Qsymia Experiencing Both Prescription Growth And Market Share Erosion
Seeking Alpha
Wed, 02/18/15 - 10:52 am
Vivus
Qsymia
obesity
Orexigen
Arena Pharmaceuticals
Contrave
Belviq
Orexigen Provides Progress Update on Mysimba European Marketing Authorization
Yahoo
Mon, 02/9/15 - 06:16 pm
Orexigen
Europe
Mysimba
Contrave
Orexigen: Contrave Scripts Slow Down - Competition Lowers Price
Seeking Alpha
Tue, 02/3/15 - 09:01 am
Orexigen
Contrave
obesity
Arena - Flat Scripts Is Not A Good Start To 2015
Seeking Alpha
Wed, 01/28/15 - 08:06 am
Arena Pharmaceuticals
Eisai
Belviq
obesity
Contrave
Orexigen
Orexigen Scripts Continue Impressive Track
Seeking Alpha
Wed, 01/21/15 - 06:02 pm
Orexigen
obesity
Contrave
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
APD334
Vivus
Qsymia
EnteroMedics
devices
Maestro System
Novo Nordisk
Saxenda
Orexigen's Contrave May Have Pricing Competition
Seeking Alpha
Mon, 01/12/15 - 09:47 am
Orexigen
Contrave
drug pricing
Belviq
Arena Pharmaceuticals
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
TheStreet.com
Fri, 01/9/15 - 09:17 am
Celgene
Gilead Sciences
Express Scripts
Biogen Idec
Amicus Therapeutics
NPS Pharmaceuticals
Sanofi
Acadia
Orexigen
Pharmacyclics
Vertex Pharmaceuticals
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Orexigen - Contrave Script Numbers Remain Impressive
Seeking Alpha
Mon, 12/22/14 - 04:52 pm
Orexigen
Contrave
obesity
Orexigen diet pill recommended for approval in Europe
Yahoo/Reuters
Fri, 12/19/14 - 09:46 am
Orexigen
obesity
Contrave
Europe
Mysimba
Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals
Adam on Biotech Stocks
Fri, 12/12/14 - 12:33 pm
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
Vivus
Qsymia
Assessing The Beginnings Of The Orexigen Launch Of Contrave
Seeking Alpha
Wed, 12/10/14 - 05:47 pm
Contrave
obesity
Orexigen
drug launches
Takeda
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »